Purchase this article with an account.
Celine Saade, Magdalena Krzystolik, Paul B. Greenberg; Reticular drusen and systemic disease in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2413.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To investigate the association between systemic disease and reticular drusen in age-related macular degeneration (AMD).
In this retrospective study, 45 consecutive patients with early AMD according to AREDS classification and reticular drusen in at least one eye were assigned to the study group and were age-matched to 45 consecutive patients with early AMD without reticular drusen in at least one eye in the control group. The Charlson Comorbidity Index (CCI), cardiovascular (CV) risk factors and the status of the fellow eye were compared between both groups using the Student t-test and Chi-squared test.
The CCI score and CV risk factors were not statistically different between the study and control groups. Advanced AMD in the fellow eye was significantly more prevalent in patients with reticular drusen (p-0.02).
In AMD, reticular drusen were significantly associated with more severe AMD but not with increased systemic disease burden.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.
Figure 1. Reticular drusen as seen on spectral domain optical coherence tomography (SD-OCT).
This PDF is available to Subscribers Only